Navigation Links
Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
Date:6/3/2008

VANCOUVER, June 3 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced the completion of U.S. clinical trial enrolment for its novel Bio-Seal lung biopsy track plug.

"Our proprietary Bio-Seal product represents a potentially significant improvement in the technology used to diagnose lung cancer," said Dr. William Hunter, President and CEO of Angiotech. "We look forward to a review of the clinical trial data and are hopeful that the data will demonstrate a considerable reduction in the side effects related to lung biopsy procedures."

Bio-Seal is a novel technology designed to reduce the incidence of post-operative pneumothorax (collapsed lung) in patients who undergo lung biopsy procedures. The technology involves the placement of an expanding hydrogel plug along the biopsy needle track during the procedure, closing off the track to subsequent influx of air into the chest during respiration after the biopsy needle is withdrawn. The seal is airtight and the plug is absorbed into the body after healing of the puncture site has occurred

The primary endpoint of the Bio-Seal study is a reduction in the incidence of pneumothorax in patients undergoing lung biopsy procedures when compared with patients who do not receive the Bio-Seal product. The product has already received CE Mark approval and is available for commercial sale in the EU.

Forward Looking Statements

--------------------------

Statements contained in this press release that are not based on historical fact, including without limitation statements containing the words "believes," "may," "plans," "will," "estimate," "continue," "anticip
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Angiotech appoints Hank McKinnell to its Board of Directors
2. Angiotech to participate in Bank of America Health Care Conference
3. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
4. Angiotech elects to suspend Vascular Wrap(TM) pivotal clinical trials
5. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
6. Angiotechs novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
7. Angiotech announces director resignation
8. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
9. Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
10. 960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotechs Novel 5-FU Central Venous Catheter
11. Angiotech to participate in Lehman Brothers Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... Imaging Diagnostic,Sys...in laser optical breast,imaging, announced today ...,adjunct to mammography is featured in the Decembe...o: http://www.newscom.com/cgi-bin/prnh/20040412/...logist at Charite Hospital in Berlin,Germany, au...
(Date:12/4/2008)...Newswire-FirstCall/ -- Raymond J. De Hont, Chairma...on (NYSE: MPR ), announced today that the Company...r 3, 2008, declared a quarterly dividend of $0.06 ...s of record at the close of business on February 2... over the same period last year. , , This i...
(Date:12/4/2008)...e/ -- Azur Pharma Limited ("Azur") today,announce...with BioSante,Pharmaceuticals, Inc ("BioSante")(N...n(TM). Elestrin is a fast drying gel formulation o...of moderate to severe vasomotor symptoms,associat...S. Food and Drug,Administration ("FDA") in Decemb...
(Date:12/4/2008)...ec. 4 Peregrine Pharma...that it will release its financial results for the..., 2008 at 7:00 a.m. EST and will host a conference...a.m. EST on the same day. , , Peregrine,s ...or the second quarter ended October 31, 2008 and w...
Breaking Biology Technology:Imaging Diagnostic Systems CT Laser Mammography (CTLM) Technology Featured in Peer-Reviewed Journal 2Met-Pro Corporation Declares Quarterly Dividend 2Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results 2
...eus assays • toxicology • image analysis...ucleus induction is a key characteristic of genoto...n resulting from DNA strand breakage (clastogens) ...ens) is an important component of toxicology scree...ronucleus assays is time consuming and subject to ...
...1 , Rao S. Takkellapati 1 , Kate Lavrenov 1 , Scot... GE Healthcare, Piscataway, NJ, USA , , ...f Cambridge, Cambridge, UK , , ,...most commonly used methods for amplification of ge...diated PCR is one of several current strategies be...
...er • apoptosis • multiplexing &bull... represents a gene-directed, morphologically and b...h. Inappropriate control of apoptosis is associate... AIDS, neurodegenerative diseases, and ischaemic s...is is extremely important when considering the eff...
...l vector • viral transduction • EGFP &bu... , There is a requirement in the drug disc...arising from primary screens and to validate those... also a need in early-stage drug discovery to iden... of, a plethora of molecular targets involved in s...
Other Biology Technology:Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 2Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 3Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 4Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 5GenomiPhi: protocol for BAC amplification and fabrication of slides for array CGH 2GenomiPhi: protocol for BAC amplification and fabrication of slides for array CGH 3GenomiPhi: protocol for BAC amplification and fabrication of slides for array CGH 4The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 2The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 3The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 4The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 5The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 6The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays 7Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 2Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 3Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 4Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 5Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 6Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 7Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 8Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 9Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 10
(Date:12/3/2008)...utive director of the International Energy Agency,... 9 at Rice University,s Baker Institute for Public... Is the world facing a supply crunch because of ge...Kyoto policy framework might stabilize greenhouse ... might such a policy framework have on future ener...
(Date:12/3/2008)...2008. The first 5-year forest inventory report for...e to the public: Oregon,s Forest Resources, 2001-2...t. , Here are some key findings from the report:...s; about half of Oregon,s total land area of 61 mi...other uses particularly near urban areas. The rate...
(Date:12/3/2008)...sity study suggests that evolution can behave as d... on an energy-efficient style of four-footed runni...eem to have evolved a profoundly inefficient gait,...w motion. , "It is usually assumed that efficien...itt, a Duke associate professor of evolutionary an...
(Date:12/3/2008)...ldren failing to take their medication for a range... part of a new university research project. , Th...he University of Nottingham and The University of ...hildren with asthma, diabetes, congenital heart di...t prevent them from taking medicines prescribed fo...
Breaking Biology News(10 mins):'World Energy Outlook' to be presented at Rice University Dec. 9 2Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Dogs chase efficiently, but cats skulk counterintuitively 2A spoonful of sugar? 2A spoonful of sugar? 3CVS Caremark Launches the 2008 Season of the CVS Caremark All Kids Can 28TM 29 Baseball Camps at Fenway Park 21598 1CVS Caremark Launches the 2008 Season of the CVS Caremark All Kids Can 28TM 29 Baseball Camps at Fenway Park 21598 2Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX 4 in Allergic Rhinitis 2395 1Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX 4 in Allergic Rhinitis 2395 2European businesses not properly advised on how to prepare for flu pandemic 21593 1European businesses not properly advised on how to prepare for flu pandemic 21593 2Disturbed rest activity linked to mortality in older men 21589 1Disturbed rest activity linked to mortality in older men 21589 2
...he fruitfly genome, Johns Hopkins scientists have ...ll migration and simultaneously captured a global ...the move. , The study, to be published April 3 in...nding cell migration and perhaps controlling cance...iginal tumor, which are what eventually kills most...
...ly and Virginia Tech in the United States have det...ible for the production xanthurenic acid (XA) in A... XA plays a key role in the sexual reproduction of.... gambiae mosquitoes. Interfering with the formati...gs and insecticides to block malaria transmission....
...w that regular use of popular prescription pain re... to 71 percent and may offer similar benefit in th... , The study findings were released today at the a...er Research in Washington, D.C. , "We believe th... inhibitors have significant chemopreventive effec...
...r ants it,s a way of life! Scientists at the Unive... to learn how to visually judge the height of hori...l under it without slowing down. Tobias Seidl will... Annual Meeting for the Society for Experimental B...ly scurry around at high speeds whilst foraging to...
Other Biology News:Researchers identify genes in fruitflies that may shed light on human cancer spread 2Oxidation defense in mosquitoes benefits malaria parasite 2COX-2 inhibitors significantly reduce risk of cancer 2
Eppendorf tube holder, for Tube rack 175 x 12 mm, 100. Category: Chromatography Systems & Accessories, Systems.
Highly efficient delivery of siRNA while maintaining high cell viability , Electroporate up to 96 samples simultaneously , Fast: less than one hour from cell harvest to post-electroporation incub
Mouse CXCR3 Allophycocyanin MAb (Clone 220803)
Request Info
Biology Products: